Corporate greed and medical complicity fueled a $250,000 drug

Internal medicine and pulmonary physician Bharat Desai discusses his article "How Acthar Gel became a $250,000 drug." Bharat shares the shocking moment he realized an obsolete pituitary extract from 1952 was being sold for the price of a house. He explains how pharmaceutical companies exploited regulatory loopholes to reclassify a cheap animal derivative as a specialty biologic and effectively monopolize the market despite the existence of superior synthetic alternatives like prednisone. The conversation exposes the deep rot within the medical profession where key opinion leaders and institutions accepted industry funding to promote a physiological absurdity over evidence-based care. We must question how intellectual surrender allows corporate greed to exploit the very patients doctors are sworn to protect.

Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story.

PARTNER WITH KEVINMD → https://kevinmd.com/influencer

SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast

RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended